RELEGARD THERAPEUTIC VAGINAL GEL WITH APPLICATOR

Manufacturer
BLANSETT PHARMACAL CO
Effective date
2017-03-20
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:23:39

Label at a glance#

ProductRELEGARD
Active ingredientACETIC ACID, OXYQUINOLINE
Label structure7 sections

Dosage and administration

TO OPEN: USE TOP OF CAP TO TWIST OFF SEAL. FOR VAGINAL USE ONLY.

Label contents#

Full prescribing information#

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

TO OPEN: USE TOP OF CAP TO TWIST OFF SEAL.

FOR VAGINAL USE ONLY.

SPL UNCLASSIFIED SECTION

CONTAINS: GLACIAL ACETIC ACID 0.9%, OXYQUINOLINE 0.025%, PRESERVATIVE, GLYCERIN, LACTIC ACID BUFFER, POLYETHYLENE GLYCOL 4500 AND PURIFIED WATER. THE PH OF 3.8 - 4.3 IS ADJUSTED USING 1N POTASSIUM HYDROXIDE.

SPL UNCLASSIFIED SECTION

DO NOT USE IF TAMPER-RESISTANT SEAL AT OPENING HAS BEEN DISTURBED OR IS NOT VISIBLE. IF THIS SEAL HAS BEEN PUNCTURED OR IS NOT VISIBLE, RETURN PRODUCT TO PLACE OF PURCHASE.

SPL UNCLASSIFIED SECTION

STORE AT ROOM TEMPERATURE.

SPL UNCLASSIFIED SECTION

DO NOT TAKE BY MOUTH OR USE IN EYES.

SPL UNCLASSIFIED SECTION

COMPLETE PRESCRIBING INFORMATION IS ENCLOSED.

THIS BOX CONTAINS ONE APPLICATOR.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Relagard proof 7.25.02_Page_1Relagard proof 7.25.02_Page_1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
543873acetic acid 0.9 % / oxyquinoline sulfate 0.025 % Vaginal GelPSN1
543879Relagard 0.9 % / 0.025 % Vaginal GelPSN1
543879acetic acid 0.009 MG/MG / oxyquinoline sulfate 0.00025 MG/MG Vaginal Gel [Relagard]SBD1
543873acetic acid 0.009 MG/MG / oxyquinoline sulfate 0.00025 MG/MG Vaginal GelSCD1
543873acetic acid 0.9 % / oxyquinoline sulfate 0.025 % Vaginal GelSY1
543879Relagard (acetic acid 0.9 % / oxyquinoline sulfate 0.025 % ) Vaginal GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51674-0130-52020-01-31C16284748780-19d75b9d1-058e-f424-e053-dadaa90a57ceRELEGARD THERAPEUTIC VAGINAL GEL WITH APPLICATOR

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51674-0130-5RELEGARD50 mL in 1 TUBEGEL501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51674-0130RELEGARD (GLACIAL ACETIC ACID, OXYQUINOLINE) GEL [BLANSETT PHARMACAL CO]1Legacy NDC, 1 package rows20170321_dd1b4ad8-08f2-4412-8a98-2d82ef35f053.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51674-0130-5GM - Gram51674-0130ad49490d-c89d-49ee-b076-9c99addf108812017-04-05

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51674-013051674-0130-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
85f9ed27-9fce-4cd5-9cb2-7dc9d6c06cb1dd1b4ad8-08f2-4412-8a98-2d82ef35f0532017-03-20Exact identifier
spl id: 85f9ed27-9fce-4cd5-9cb2-7dc9d6c06cb1
spl set id: dd1b4ad8-08f2-4412-8a98-2d82ef35f053

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.